Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Buy
188,538
+18,093
+11% +$1.11M 0.43% 74
2026
Q1
$11.8M Buy
170,445
+158,027
+1,273% +$12.2M 0.48% 71
2025
Q4
$945K Hold
12,418
0.14% 76
2025
Q3
$1.07M Sell
12,418
-3,595
-22% -$271K 0.15% 80
2025
Q2
$1.09M Hold
16,013
0.15% 81
2025
Q1
$953K Sell
16,013
-5,000
-24% -$317K 0.17% 77
2024
Q4
$1.27M Sell
21,013
-3,082
-13% -$189K 0.22% 71
2024
Q3
$1.74M Hold
24,095
0.3% 61
2024
Q2
$1.7M Hold
24,095
0.31% 61
2024
Q1
$1.92M Hold
24,095
0.34% 59
2023
Q4
$2.16M Sell
24,095
-10,211
-30% -$879K 0.44% 46
2023
Q3
$3.38M Buy
34,306
+16,758
+95% +$1.73M 0.68% 35
2023
Q2
$1.79M Buy
17,548
+636
+4% +$62.9K 0.32% 54
2023
Q1
$1.9M Buy
+16,912
New +$1.87M 0.27% 60

Other funds holding APTV

Mirova's APTV Position: Q2 2026 in Review

Mirova increased its Aptiv (APTV) stake by 11% in Q2 2026, buying an estimated $1.11M and bringing the position to 188,538 shares worth $11.6M. The position accounts for 0.43% of the portfolio, ranked #74.

Mirova first reported a position in APTV in Q1 2023 and has held it in 14 quarters since. The position peaked at $11.8M in Q1 2026. 657 funds tracked by Wall St. Rank hold APTV as of Q2 2026.

  • Mirova held 188,538 shares of Aptiv worth $11.6M as of Q2 2026.
  • Mirova bought 18,093 Aptiv shares in Q2 2026, an estimated $1.11M.
  • Aptiv made up 0.43% of Mirova's portfolio in Q2 2026, its #74 holding.
  • Mirova first reported a position in Aptiv in Q1 2023 and has held it in 14 quarters since.
  • Mirova's Aptiv position peaked at $11.8M in Q1 2026.
  • 657 funds tracked by Wall St. Rank held Aptiv as of Q2 2026.

Based on Mirova's 13F filing for Q2 2026, filed 13 Aug 2026.